Two first-line cutaneous melanoma patients - one patient who was dose escalated from 70 mg to 210 mg and finally to 350 mg experienced a confirmed partial response (PR) at the higher dose; one patient ...

From unconventional influencer alliances to cross-industry tie-ups, these partnerships have not only captivated attention but also sparked widespread conversations ...

Greetings, and welcome to the Olo third-quarter 2024 earnings conference call. [Operator instructions] As a reminder, this ...